Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Connection between depression and osteoporosis

31.10.2006
Depression can cause a loss of bone mass, leading to osteoporosis and fractures, say researchers at the Hebrew University of Jerusalem.

The researchers say their findings constitute a significant step forward in understanding the interaction between the mind and the skeletal system. Based on their findings, the researchers have already been able to demonstrate the efficacy of anti-depressant drugs in preventing bone mass loss.

The findings of the Hebrew University researchers are being published this week in the American journal PNAS (Proceedings of the National Academy of Sciences).

Participants in the project were researchers from the university’s Brain and Behavior Laboratory, headed by Prof. Raz Yirmia; from the Bone Laboratory, headed by Prof. Itai Bab; and from the Brain Trauma Laboratory, headed by Prof. Esther Shohami. Also participating were doctoral students Inbal Goshen, Alon Bajayo , Tirza Kreisel, Sharon Feldman and Yosef Tam

Loss of bone mass is the leading cause of osteoporosis and bone fractures among the aged in general and among post-menopausal women in particular. Several studies indicate that people with major depression generally have a lower bone mass density compared to control samples; however, no direct link between these two conditions has been established.

In order to examine the connection between depression and bone mass loss, the researchers used a model involving laboratory mice. Following the induction of a depression-like condition, the mice developed behavioral symptoms mirroring those seen in depressed humans, including a reduction in pleasurable activity and in social interaction.

After four weeks in a depressed state, the laboratory animals showed a dramatic bone mass loss, including in the hip bone and vertebrae. This loss was caused by impairment in the bone renewal process, which is essential to maintaining normal bone density. This impairment was caused by a reduction in the number of bone-building cells, which are called osteoblasts.

The laboratory tests showed that chronic use of an anti-depressant drug halted not only the depression itself but also the loss of bone density.

The researchers were also able to describe the process connecting depression to the skeletal structure. They found that depression sets off a neural system connecting the brain to the internal organs, including the skeleton. This system is called the “sympathetic nervous system.” Its activation causes the secretion within the bone of a chemical compound called noradrenaline, which has a detrimental effect on the bone-building cells. The researchers were able to show that chronic treatment with a drug that blocks noradrenaline in the bone also blocks the detrimental influence of depression on the bone.

This research serves as the basis for new, efficient drugs for treatment of osteoporosis, which is the most prevalent degenerative disease in western society. The Hebrew University’s technology transfer company, Yissum, has applied for a patent for treatment of osteoporosis through anti-depressants.

“The connection between the brain and the skeleton in general, and the influence of depression on bone mass in particular is a new area of research about which we still know very little,” said Prof. Yirmiya. “The new findings, which we have discovered in the Hebrew University laboratories, point for the first time to depression as an important element in causing bone mass loss and osteoporosis.”

Prof. Bab said that “together with other research which we have published in the past year, we have developed a new area of research that we call ‘neuro-psycho-osteology,’ which deals with the connection between the brain, mental states and the skeleton.”

The research at the Hebrew University was carried out with funding from the Bikura program of the Israel National Science Foundation.

Jerry Barach | alfa
Further information:
http://www.huji.ac.il

More articles from Health and Medicine:

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

nachricht The gut microbiota plays a key role in treatment with classic diabetes medication
01.06.2017 | University of Gothenburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>